Evidence map›Paper›PMID 39409100›Full record

Trial reportInternational journal of molecular sciences2024

OXY-SCORE and Volatile Anesthetics: A New Perspective of Oxidative Stress in EndoVascular Aneurysm Repair-A Randomized Clinical Trial.

Alba Burgos-Santamaría, Pilar Rodríguez-Rodríguez, Ana Arnalich-Montiel, Silvia M Arribas, Carmen Fernández-Riveira, I María Barrio-Pérez, Javier Río, José Manuel Ligero, Begoña Quintana-Villamandos

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alba Burgos-SantamaríaDepartment of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.ORCID 0000-0001-7403-1668
Pilar Rodríguez-RodríguezDepartment of Physiology, Faculty of Medicine, Autónoma University, 28029 Madrid, Spain.
Ana Arnalich-MontielDepartment of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.
Silvia M ArribasDepartment of Physiology, Faculty of Medicine, Autónoma University, 28029 Madrid, Spain.
Carmen Fernández-RiveiraDepartment of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.
I María Barrio-PérezDepartment of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.
Javier RíoDepartment of Angiology and Vascular Surgery, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.
José Manuel LigeroDepartment of Angiology and Vascular Surgery, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.ORCID 0000-0003-1634-7028
Begoña Quintana-VillamandosDepartment of Anesthesia and Intensive Care, Gregorio Marañón's University Hospital, 28007 Madrid, Spain.

Funding

International Grant Anesthesia and Critical Care, Baxter S.L (2016) International Grant Anesthesia and Critical Care, Baxter S.L (2016)
6 · The paper itself

Abstract

An aortic aneurysm (AA) is a life-threatening condition. Oxidative stress may be a common pathway linking multiple mechanisms of an AA, including vascular inflammation and metalloproteinase activity. Endovascular aneurysm repair (EVAR) is the preferred surgical approach for AA treatment. During surgery, inflammation and ischemia-reperfusion injury occur, and reactive oxygen species (ROS) play a key role in their modulation. Increased perioperative oxidative stress is associated with higher postoperative complications. The use of volatile anesthetics during surgery has been shown to reduce oxidative stress. Individual biomarkers only partially reflect the oxidative status of the patients. A global indicator of oxidative stress (OXY-SCORE) has been validated in various pathologies. This study aimed to compare the effects of the main volatile anesthetics, sevoflurane and desflurane, on oxidative status during EVAR. Eighty consecutive patients undergoing EVAR were randomized into two groups: sevoflurane and desflurane. Plasma biomarkers of oxidative damage (protein carbonylation and malondialdehyde) and antioxidant defense (total thiols, glutathione, nitrates, superoxide dismutase, and catalase activity) were measured before surgery and 24 h after EVAR. The analysis of individual biomarkers showed no significant differences between the groups. However, the OXY-SCORE was positive in the desflurane group (indicating a shift towards antioxidants) and negative in the sevoflurane group (favoring oxidants) (

Indexed as

Anesthetics, InhalationBiomarkersDesfluraneEndovascular ProceduresOxidative StressSevofluraneAgedAged, 80 and overAntioxidantsEndovascular Aneurysm RepairFemaleHumansMaleMiddle AgedReactive Oxygen SpeciesSuperoxide DismutaseAnesthetics, InhalationAntioxidantsBiomarkersDesfluraneReactive Oxygen SpeciesSevofluraneSuperoxide Dismutaseaortic aneurysmoxidative stressOXY-SCOREvolatile anesthetics

Identifiers

PMID39409100
PMCPMC11476523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.